Browse our anti-C-MYC (MYC) Antibodies

Full name:
anti-V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) Antibodies (MYC)
On www.antibodies-online.com are 693 V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) (MYC) Antibodies from 33 different suppliers available. Additionally we are shipping C-MYC Kits (47) and C-MYC Proteins (27) and many more products for this protein. A total of 796 C-MYC products are currently listed.
Synonyms:
AU016757, bHLHe39, C-MYC, CMyc, LOC100136746, mMyc, MRTL, MYC, Myc2, MYCC, Niard, Nird, RNCMYC, zc-myc
list all antibodies Gene Name GeneID UniProt
Anti-Rat MYC MYC 24577 P09416
MYC 17869 P01108
MYC 4609 P01106

Show all species

Show all synonyms

All available anti-C-MYC Antibodies

Go to our pre-filtered search.

Top referenced anti-C-MYC Antibodies

  1. Human Polyclonal C-MYC Primary Antibody for EIA, WB - ABIN358293 : Qi, Gregory, Li, Brousal, West, Hann: p19ARF directly and differentially controls the functions of c-Myc independently of p53. in Nature 2004 (PubMed)
    Show all 5 references for 358293

  2. Human Polyclonal C-MYC Primary Antibody for IHC (p), WB - ABIN197156 : Baudino, Cleveland: The Max network gone mad. in Molecular and cellular biology 2001 (PubMed)
    Show all 4 references for 197156

  3. Human Monoclonal C-MYC Primary Antibody for IF, IHC (p) - ABIN1105578 : Liao, Thakur, Wu, Biliran, Sarkar: Perspectives on c-Myc, Cyclin D1, and their interaction in cancer formation, progression, and response to chemotherapy. in Critical reviews in oncogenesis 2008 (PubMed)
    Show all 4 references for 1105578

  4. Human Polyclonal C-MYC Primary Antibody for WB - ABIN197158 : Blackwood, Eisenman: Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. in Science (New York, N.Y.) 1991 (PubMed)
    Show all 4 references for 197158

  5. Human Polyclonal C-MYC Primary Antibody for IF - ABIN401560 : Henriksson, Lüscher: Proteins of the Myc network: essential regulators of cell growth and differentiation. in Advances in cancer research 1996 (PubMed)
    Show all 4 references for 401560

  6. Human Monoclonal C-MYC Primary Antibody for EIA, FACS - ABIN119684 : Spandidos, Pintzas, Kakkanas, Yiagnisis, Mahera, Patra, Agnantis: Elevated expression of the myc gene in human benign and malignant breast lesions compared to normal tissue. in Anticancer research 1988 (PubMed)
    Show all 2 references for 119684

  7. Human Monoclonal C-MYC Primary Antibody for FACS, IHC (fro) - ABIN119682 : Evan, Lewis, Ramsay, Bishop: Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. in Molecular and cellular biology 1986 (PubMed)
    Show all 2 references for 119682

  8. Mammalian Monoclonal C-MYC Primary Antibody for IF, IP - ABIN1105582 : Watanabe, Honma, Furusawa, Sakurai, Sato: Preparation of enzymatically active human Myc-tagged-NCre recombinase exhibiting immunoreactivity with anti-Myc antibody. in Molecular reproduction and development 2006 (PubMed)

  9. Human Polyclonal C-MYC Primary Antibody for WB - ABIN2668789 : Kohn, Yang, Du, Nagano, Van Schyndle, Herrmann, Heldman, Chen, Stuelten, Flanders, Wakefield: Biological responses to TGF-β in the mammary epithelium show a complex dependency on Smad3 gene dosage with important implications for tumor progression. in Molecular cancer research : MCR 2012 (PubMed)

More Antibodies against C-MYC Interaction Partners

Mouse (Murine) V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) (MYC) interaction partners

  1. Data, including data from studies in cells from knockout mice, suggest that Prmt1 (show PRMT1 Antibodies) activity was necessary for c-Myc binding to acetyltransferase p300 (show NOTCH1 Antibodies) in myeloid cells; Prmt1 (show PRMT1 Antibodies) inhibition decreases p300 (show NOTCH1 Antibodies) recruitment to c-Myc target promoters and increased Hdac1 (show HDAC1 Antibodies) recruitment. [Prmt1 (show PRMT1 Antibodies), protein arginine N-methyltransferase 1 (show PRMT1 Antibodies); c-Myc = Proto-Oncogene (show RAB1A Antibodies) Proteins c-myc; Hdac1 (show HDAC1 Antibodies) = histone deacetylase 1 (show HDAC1 Antibodies)]

  2. MYC-dependent attenuation of GCLC (show GCLC Antibodies) by miR (show MLXIP Antibodies)-18a contributes to GSH depletion in vivo, and low GSH corresponds with increased sensitivity to oxidative stress in tumors.

  3. MYC mediates cell cycle re-entry of Trp53 (show TP53 Antibodies)-altered hepatocytes via AURKA (show AURKA Antibodies) binding.

  4. Modification of the tumor microenvironment in KRAS or c-MYC-induced ovarian cancer-associated peritonitis has been described.

  5. Myc can substitute for Notch1 (show NOTCH1 Antibodies) in leukemogenesis

  6. interplay between MATalpha1, c-Myc, and Maf (show MAF Antibodies) proteins, and their deregulation during chronic cholestasis may facilitate cholangiocarcinoma oncogenesis

  7. our results show how MYC drives the production of specific eicosanoids critical for lung cancer cell survival and proliferation

  8. Early generated B1 B cells with restricted BCRs become chronic lymphocytic leukemia with continued c-Myc and low Bmf (show BMF Antibodies) expression

  9. Data (including data from studies using transgenic mice) suggest that expression of c-Myc in liver can be correlated with progression, regression, and recurrence of hepatocellular carcinoma (using a specific mouse model).

  10. TCF7L2 (show TCF7L2 Antibodies) mediates canonic Wnt (show WNT2 Antibodies)/beta-catenin (show CTNNB1 Antibodies) signaling and c-Myc upregulation during abnormal cardiac remodeling in heart failure and suppression of Wnt (show WNT2 Antibodies)/beta-catenin (show CTNNB1 Antibodies) to c-Myc axis can be explored for preventing and treating heart failure.

Zebrafish V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) (MYC) interaction partners

  1. Apoptosis was also observed with myca expression; introduction of homozygous tp53 (show TP53 Antibodies)(-/-) mutation into the myca transgenic fish reduced apoptosis and accelerated tumor progression.

  2. MYC down-regulation induces mitochondrial apoptosis in T lymphoblasts.

Human V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) (MYC) interaction partners

  1. The MUC1 (show MUC1 Antibodies) oncoprotein was identified as the critical driver of (extracellular vesicle) EV-mediated myeloid-derived suppressor cells expansion in AML (show RUNX1 Antibodies). microRNA miR34a acts as the regulatory mechanism by which MUC1 (show MUC1 Antibodies) drives c-myc expression in AML (show RUNX1 Antibodies) cells and EVs.

  2. Diffuse large B-cell lymphoma with concurrent high MYC and BCL2 (show BCL2 Antibodies) expression shows evidence of active B-cell receptor signaling

  3. Emetine induced cell death in primary refractory lymphoma cells with MYC rearrangement.

  4. The presence of MYC amplifications in two cases of cutaneous angiosarcoma secondary to chronic lymphedema of morbid obesity is described

  5. MYC-dependent attenuation of GCLC (show GCLC Antibodies) by miR (show MLXIP Antibodies)-18a contributes to GSH depletion in vivo, and low GSH corresponds with increased sensitivity to oxidative stress in tumors.

  6. Our data reveal the existence of a feedback loop between c-Myc and lncRNA-MIF (show AMH Antibodies), through which c-Myc protein stability is finely controlled. Additionally, we show that the lncRNA-MIF (show AMH Antibodies) inhibits aerobic glycolysis and tumorigenesis by suppressing c-Myc and miR (show MLXIP Antibodies)-586.

  7. DNA methylation (show HELLS Antibodies) levels at CpG sites in MYC may be associated specifically with the risk of aggressive prostate cancer.

  8. PSME3 (show PSME3 Antibodies) plays an oncogenic role in pancreatic cancer by inhibiting c-Myc degradation to promote glycolysis.

  9. ADA3 (show TADA3 Antibodies) overexpression enhances cell proliferation that is associated with increased expression of c-MYC. Expression patterns with respect to ADA3 (show TADA3 Antibodies)/c-MYC can divide patients into four significantly different subgroups, with c-MYC High and ADA3 (show TADA3 Antibodies) Low status independently predicting poor survival in patients.

  10. Data suggest that sulforaphane (SFN (show SFN Antibodies)) exerted anticancer functions through upregulation of microRNA miR (show MLXIP Antibodies)-214, which in turn targets the coding region of c-MYC and beta-catenin (show CTNNB1 Antibodies).

Rabbit V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) (MYC) interaction partners

  1. report the isolation of complete coding regions of rabbit SOX2, KLF4, C-MYC and NANOG, which encode transcription factors that play crucial regulatory roles during early mammalian embryonic development

Cow (Bovine) V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) (MYC) interaction partners

  1. Ouabain-induced proliferation might be attributed, at least in part, to decrease of intracellular free calcium and increase of c-myc mRNA expression, and that may be directly or indirectly involved in regulation of blood pressure.

C-MYC (MYC) Antigen Profile

Antigen Summary

The protein encoded by this gene is a multifunctional, nuclear phosphoprotein that plays a role in cell cycle progression, apoptosis and cellular transformation. It functions as a transcription factor that regulates transcription of specific target genes. Mutations, overexpression, rearrangement and translocation of this gene have been associated with a variety of hematopoietic tumors, leukemias and lymphomas, including Burkitt lymphoma. There is evidence to show that alternative translation initiations from an upstream, in-frame non-AUG (CUG) and a downstream AUG start site result in the production of two isoforms with distinct N-termini. The synthesis of non-AUG initiated protein is suppressed in Burkitt's lymphomas, suggesting its importance in the normal function of this gene.

Alternative names and synonyms associated with C-MYC (MYC)

  • v-myc myelocytomatosis viral oncogene homolog (LOC100136746) antibody
  • myelocytomatosis oncogene (Myc) antibody
  • myelocytomatosis oncogene a (myca) antibody
  • v-myc avian myelocytomatosis viral oncogene homolog (MYC) antibody
  • v-myc myelocytomatosis viral oncogene homolog (MYC) antibody
  • v-myc myelocytomatosis viral oncogene homolog (avian) (MYC) antibody
  • AU016757 antibody
  • bHLHe39 antibody
  • C-MYC antibody
  • CMyc antibody
  • LOC100136746 antibody
  • mMyc antibody
  • MRTL antibody
  • MYC antibody
  • Myc2 antibody
  • MYCC antibody
  • Niard antibody
  • Nird antibody
  • RNCMYC antibody
  • zc-myc antibody

Protein level used designations for MYC

v-myc myelocytomatosis viral oncogene homolog , Avian myelocytomatosis viral (v-myc) oncogene homolog , myc proto-oncogene protein , myelocytomatosis viral oncogene homolog , proto-oncogene c-Myc , transcription factor p64 , v-myc avian myelocytomatosis viral oncogene homolog , c-myc proto-oncogene , C-Myc1 , c-Myc-A , cellular myelocytomatosis oncogene , cmyca , transcriptional regulator Myc-A , avian myelocytomatosis viral oncogene homolog , class E basic helix-loop-helix protein 39 , myc-related translation/localization regulatory factor , avian myelocytomatosis viral (v-myc) oncogene homolog , c-Myc , Proto-oncogene c-Myc , Transcription factor p64 , Myc proto-oncogene protein

GENE ID SPECIES
100136746 Oncorhynchus mykiss
24577 Rattus norvegicus
17869 Mus musculus
30686 Danio rerio
4609 Homo sapiens
420332 Gallus gallus
100327265 Oryctolagus cuniculus
403924 Canis lupus familiaris
448810 Sus scrofa
511077 Bos taurus
100379628 Felis catus
443447 Ovis aries
694626 Macaca mulatta
464393 Pan troglodytes
100407754 Callithrix jacchus
100972175 Pan paniscus
Selected quality suppliers for anti-C-MYC (MYC) Antibodies
Did you look for something else?